Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis
E Balsells, L Guillot, H Nair, MH Kyaw - PloS one, 2017 - journals.plos.org
Background Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13)
has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly …
has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly …
Making sense of differences in pneumococcal serotype replacement
JA Lewnard, WP Hanage - The Lancet Infectious Diseases, 2019 - thelancet.com
Serotype replacement in invasive pneumococcal disease threatens to undermine the most
costly vaccination programme currently undertaken. However, the effects of replacement on …
costly vaccination programme currently undertaken. However, the effects of replacement on …
Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000–17: a prospective national observational cohort study
SN Ladhani, S Collins, A Djennad… - The Lancet Infectious …, 2018 - thelancet.com
Summary Background Pneumococcal conjugate vaccines (PCVs) have substantially
reduced the incidence of invasive pneumococcal disease caused by vaccine serotypes; …
reduced the incidence of invasive pneumococcal disease caused by vaccine serotypes; …
[HTML][HTML] Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an …
Background The 13-valent pneumococcal conjugate vaccine (PCV13) protects against key
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7) …
serotypes that increased after routine immunisation with the seven-valent vaccine (PCV7) …
[HTML][HTML] Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance …
Background Ten-valent pneumococcal conjugate vaccine (PCV10), delivered at 6, 10, and
14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up …
14 weeks of age was introduced in Kenya in January, 2011, accompanied by a catch-up …
Streptococcus pneumoniae serotype 19A: worldwide epidemiology
R Isturiz, HL Sings, B Hilton, A Arguedas… - Expert review of …, 2017 - Taylor & Francis
Introduction: Streptococcus pneumoniae causes mucosal and invasive diseases with high
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
morbidity and mortality. Introduction of the 7-valent pneumococcal conjugate vaccine …
Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1+ 1) compared with two primary doses and a booster (2+ 1) in UK infants: a …
D Goldblatt, J Southern, NJ Andrews… - The Lancet Infectious …, 2018 - thelancet.com
Background Infants in the UK were first offered a pneumococcal conjugate vaccine (PCV7)
in 2006, given at 2 and 4 months of age and a booster dose at 13 months (2+ 1 schedule). A …
in 2006, given at 2 and 4 months of age and a booster dose at 13 months (2+ 1 schedule). A …
Pneumococcal carriage in children and their household contacts six years after introduction of the 13-valent pneumococcal conjugate vaccine in England
J Southern, N Andrews, P Sandu, CL Sheppard… - PLoS …, 2018 - journals.plos.org
Background In April 2010, 13-valent pneumococcal conjugate vaccine (PCV13) replaced
PCV7 in the infant immunisation schedule in England and Wales. Despite limited serotype …
PCV7 in the infant immunisation schedule in England and Wales. Despite limited serotype …
Pneumococcal serotype evolution in Western Europe
M Tin Tin Htar, D Christopoulou, HJ Schmitt - BMC infectious diseases, 2015 - Springer
Background Pneumococcal diseases remain a leading cause of vaccine-preventable death
worldwide in children< 5 years of age. The seven-valent pneumococcal conjugate vaccine …
worldwide in children< 5 years of age. The seven-valent pneumococcal conjugate vaccine …
[HTML][HTML] Five winters of pneumococcal serotype replacement in UK carriage following PCV introduction
RA Gladstone, JM Jefferies, AS Tocheva, KR Beard… - Vaccine, 2015 - Elsevier
The seven-valent pneumococcal conjugate vaccine (PCV7) was added to the UK national
immunisation programme in September 2006. PCV13 replaced PCV7 in April 2010. As …
immunisation programme in September 2006. PCV13 replaced PCV7 in April 2010. As …